TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharmaxim AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
174,499
|
153,294
|
182,565 |
| Financial expenses |
915
|
419
|
216 |
| Earnings before taxes |
11,659
|
9,329
|
8,314 |
| EBITDA |
12,974
|
9,854
|
9,245 |
| Total assets |
90,797
|
91,626
|
87,529 |
| Current assets |
59,932
|
63,543
|
58,707 |
| Current liabilities |
28,320
|
47,644
|
39,797 |
| Equity capital |
44,873
|
41,131
|
44,048 |
| - share capital |
1,150
|
1,150
|
1,150 |
| Employees (average) |
14
|
15
|
16 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
49.4%
|
44.9%
|
50.3% |
| Turnover per employee |
12,464
|
10,220
|
11,410 |
| Profit as a percentage of turnover |
6.7%
|
6.1%
|
4.6% |
| Return on assets (ROA) |
13.8%
|
10.6%
|
9.7% |
| Current ratio |
211.6%
|
133.4%
|
147.5% |
| Return on equity (ROE) |
26.0%
|
22.7%
|
18.9% |
| Change turnover |
21,205
|
-29,271
|
-20,393 |
| Change turnover % |
14%
|
-16%
|
-10% |
| Chg. No. of employees |
-1
|
-1
|
-4 |
| Chg. No. of employees % |
-7%
|
-6%
|
-20% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.